P Peptide Calculator
Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Pemvidutide and BAC Water Mix

Pemvidutide Reconstitution Calculator

Reviewed by · Pharmacist and Scientific Reviewer

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Pemvidutide Titration Schedule

ParameterDetails
Doses1.2 / 1.8 / 2.4 mg
RouteSC, once weekly
Titration (1.2/1.8 mg)None — direct start
Titration (2.4 mg)4-week titration
Phase 31–2 monthly steps

Investigational (FDA Breakthrough Therapy for MASH). The 1.2 and 1.8 mg doses were administered without titration in trials — unique in the class; the Phase 3 program adds 1–2 monthly escalation steps.

Possible vial strengths:

What Is It?

Pemvidutide

Dual GLP-1 / glucagon agonist in metabolic research.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Pemvidutide

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Pemvidutide Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Pemvidutide is an investigational peptide-based GLP-1/glucagon dual receptor agonist developed by Altimmune. It is being studied for obesity and MASH, but it is not FDA-approved or commercially available in the United States.
Pemvidutide activates GLP-1 and glucagon receptors. GLP-1 is linked to appetite reduction, while glucagon activity is being studied for energy expenditure, liver fat reduction, lipid changes, and broader metabolic effects.
A reconstitution calculator only gives concentration math, not a treatment plan. For example, 12 mg mixed to a final volume of 5 mL gives 2.4 mg/mL; 1.2 mg equals 0.50 mL or 50 U-100 units, 1.8 mg equals 0.75 mL or 75 units, and 2.4 mg equals 1.00 mL or 100 units.
No. Pemvidutide has FDA Breakthrough Therapy Designation for MASH, but that is not the same as approval. It remains a clinical-stage drug candidate, with Phase 3 MASH development planned rather than pharmacy access
Pemvidutide is GLP-1/glucagon based, semaglutide is GLP-1 based, and tirzepatide is GLP-1/GIP based. That makes pemvidutide especially relevant to liver-fat and MASH research, but there are no completed head-to-head approval-level trials proving it is better or safer.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

More GLP-1 & Metabolic calculators

Retatrutide Semaglutide Tirzepatide Liraglutide CagriSema Cagrilintide Mazdutide Survodutide

References

  1. Harrison SA, et al. Efinopegdutide vs semaglutide in MASH (abstract lineage).

About the author

· Pharmacist and Scientific Reviewer

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides